Bionano Genomics, Inc. (BNGO) stock
BNGONasdaqLaboratory Analytical InstrumentsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 12/3083% below fair value
$0.95+0.01 (+1.29%)
Close on Nov 17, 2026Market cap $11.21MP/E –Yield –
Bionano Genomics r&d expenses
Research and development expenses are spending on new products and technology.
Bionano Genomics's R&D Expenses for the twelve months ending Jun 30, 2026 was $12.20M, down 9.6% year over year. For fiscal 2025 it was $11.37M, down 54.1% from the year before. The highest annual figure on record is $54.03M in fiscal 2023.
Annual r&d expenses
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $11.37M | -54.1% |
| FY2024 | Dec 31, 2024 | $24.80M | -54.1% |
| FY2023 | Dec 31, 2023 | $54.03M | +10.2% |
| FY2022 | Dec 31, 2022 | $49.05M | +118.1% |
| FY2021 | Dec 31, 2021 | $22.49M | +119.2% |
| FY2020 | Dec 31, 2020 | $10.26M | +12.9% |
| FY2019 | Dec 31, 2019 | $9.08M | -4.3% |
| FY2018 | Dec 31, 2018 | $9.48M | -21.0% |
| FY2017 | Dec 31, 2017 | $12.01M | – |
Quarterly r&d expenses
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $2.99M | +1.9% |
| Q1 FY2026 | Mar 31, 2026 | $3.14M | +32.4% |
| Q4 FY2025 | Dec 31, 2025 | $3.23M | -7.1% |
| Q3 FY2025 | Sep 30, 2025 | $2.84M | -39.7% |
| Q2 FY2025 | Jun 30, 2025 | $2.93M | -57.1% |
| Q1 FY2025 | Mar 31, 2025 | $2.37M | -75.8% |
| Q4 FY2024 | Dec 31, 2024 | $3.47M | -70.3% |
| Q3 FY2024 | Sep 30, 2024 | $4.72M | -65.8% |
| Q2 FY2024 | Jun 30, 2024 | $6.83M | -53.2% |
| Q1 FY2024 | Mar 31, 2024 | $9.78M | -29.8% |
| Q4 FY2023 | Dec 31, 2023 | $11.70M | -16.5% |
| Q3 FY2023 | Sep 30, 2023 | $13.79M | +8.2% |
| Q2 FY2023 | Jun 30, 2023 | $14.61M | +24.2% |
| Q1 FY2023 | Mar 31, 2023 | $13.94M | +32.4% |
| Q4 FY2022 | Dec 31, 2022 | $14.01M | +52.0% |
| Q3 FY2022 | Sep 30, 2022 | $12.74M | +95.9% |
| Q2 FY2022 | Jun 30, 2022 | $11.77M | +188.0% |
| Q1 FY2022 | Mar 31, 2022 | $10.53M | +293.1% |
| Q4 FY2021 | Dec 31, 2021 | $9.22M | +220.3% |
| Q3 FY2021 | Sep 30, 2021 | $6.51M | +182.3% |
| Q2 FY2021 | Jun 30, 2021 | $4.09M | +70.2% |
| Q1 FY2021 | Mar 31, 2021 | $2.68M | +0.1% |
| Q4 FY2020 | Dec 31, 2020 | $2.88M | +19.9% |
| Q3 FY2020 | Sep 30, 2020 | $2.30M | +6.0% |
| Q2 FY2020 | Jun 30, 2020 | $2.40M | -0.3% |
| Q1 FY2020 | Mar 31, 2020 | $2.67M | +27.3% |
| Q4 FY2019 | Dec 31, 2019 | $2.40M | -4.9% |
| Q3 FY2019 | Sep 30, 2019 | $2.17M | -13.2% |
| Q2 FY2019 | Jun 30, 2019 | $2.41M | +14.7% |
| Q1 FY2019 | Mar 31, 2019 | $2.10M | -11.3% |
| Q4 FY2018 | Dec 31, 2018 | $2.52M | +2.6% |
| Q3 FY2018 | Sep 30, 2018 | $2.51M | -15.6% |
| Q2 FY2018 | Jun 30, 2018 | $2.10M | – |
| Q1 FY2018 | Mar 31, 2018 | $2.37M | – |
| Q4 FY2017 | Dec 31, 2017 | $2.46M | – |
| Q3 FY2017 | Sep 30, 2017 | $2.97M | – |
See a number that looks wrong?